BackProject® Corporation is a leading edge company that strives to develop clinically advanced treatment systems and concepts for musculoskeletal clinicians worldwide. The ATM® Concept is the cornerstone treatment Concept developed specifically to significantly and immediately reduce pain. Back pain costs have well been documented and certainly this year will reach new heights. The annual cost in terms of lost productivity, medical expenses and workers’ compensation benefits will run into the tens of billions of dollars in the United States this year.

Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France.

Biodol Therapeutics, founded in 2015, develops first-in-class compounds for the treatment of chronic pain (CP). Biodol Therapeutics has identified the Receptor Tyrosine Kinase (RTK) FLT3 as a key player for triggering and maintaining the chronic neuropathic pain (NP) state. New findings from Biodol Therapeutics' academic partnership (Cyril Rivat and Jean Valmier at the INSERM Institute for Neurosciences in Montpellier) also demonstrated that FLT3 inhibition increases the potency of opioids for their analgesic effect, and hereby reduces their safety risks, especially addiction risk, which will help fighting the Opioid Crisis. The development of extracellular inhibitors of the FLT3 receptor, is a proprietary and key approach developed by Biodol Therapeutics.

Board of Regents of The University of Oklahoma is a private company headquartered in Norman, OK, with domestic subsidiaries, specializing in radio broadcasting stations.

Yan'an Shigaopin Biotechnology Co., Ltd., established on 2017-03-23, The business scope includes biological traditional Chinese medicine(scorpion etc.)farming,processing,Sales,preparation,food,Health products,R & D, etc.

The Kyungpook National University Hospital is located in Daegu, South Korea. It was derived from the DaeGuDongIn Hospital which had opened in 1907. It has played as centered hospital of Gyeongsangbuk-do. As 1952 Kyungpook National University is established, it is following to the Kyungpook National University Hospitals. It is known to Korean as important general hospitals.

Tianjin Medical University General Hospital (Chinese: 天津医科大学总医院) is a general hospital in the central Heping District of the Chinese metropolis of Tianjin, associated with Tianjin Medical University.

Zhaoke Pharmaceutical (Guangzhou) Ltd., a subsidiary of Lee's Pharmaceutical Holdings Ltd., is a company headquartered in Guangzhou, China, that manufactures and sells pharmaceutical products.

Shanghai Internationl Medical Center Investment Mgmt Co. Ltd. is a private company headquartered in China that provides investment management services.

Nanjing Ningdong Digital Technology Co., Ltd., established on 2018-09-06, The scope of business includes technological development in the field of digital technology,technology transfer,technical consulting,Technical Services(No licensed items);medical technology,R&D of medical devices.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Shanghai Medicilon, Inc. provides outsourced research and development services for pharmaceutical and biotechnology companies through contractual forms. Its business areas include Drug exploration and pharmaceutical research as well as Preclinical studies. Its services include chemistry services such as medical chemistry and synthetic chemistry, drug formulation, biology services such as computational biology and molecular modeling, pharmacology services such as transgenic mouse models and digestive system models, bioanalytical services, pharmacokinetic services, drug safety evaluation, and integrated projects such as chemical drug development and chemical compound druggability assessment. The company was founded by Jin Zhang Chen and Chun Lin Chen on February 2, 2004 and is headquartered in Shanghai, China.

Medicapril Biomedical Technology (Shanghai) Co., Ltd., established on 2022-03-15, Business scope includes licensed projects:pharmaceutical production;Inspection and testing service;medical service;Drug Clinical Trial Services.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments) General project:Sales of Class I Medical Devices;Sales of Class II Medical Devices;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Import and export;Technology Import and Export;Medical Research and Experimental Development;R&D and application of cell technology;Specialty Chemicals Sales(Free of Hazardous Chemicals);Biochemical product technology research and development.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)